Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The STAR™ Tumor Ablation Registry

NCT02419703 is registered in ClinicalTrials.gov with Merit Medical Systems, Inc. as lead sponsor.

NCT NCT02419703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02419703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The STAR™ Tumor Ablation Registry
Lead sponsor
Merit Medical Systems, Inc.
Phase
Observational
Overall status
Terminated
Start date
October 31, 2015
Completion date
March 20, 2017
Enrollment
65 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic lesions in vertebral bodies